William T Creasman1, Matthew F Kohler. 1. Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC 29425, USA. creasman@musc.edu
Abstract
OBJECTIVE: To determine whether lymph vascular space involvement (LVSI) in women with early cervical carcinoma is an independent prognostic factor. METHODS: The literature was reviewed using Medline and known literature to determine if LVSI is an independent risk factor as determined by multivariant analysis with survival being the end point in patients undergoing radical hysterectomy and pelvic lymphadenopathy. RESULTS: A total of 25 articles were identified that satisfied the evaluation criteria. Only three (12%) identified LVSI as an independent risk factor while 88% and 61% of those evaluated, noted lymph node metastasis and tumor size/depth of invasion to be significant risk factors for survival. CONCLUSIONS: Using LVSI as the sole determining factor for consideration of post radical hysterectomy radiotherapy appears questionable.
OBJECTIVE: To determine whether lymph vascular space involvement (LVSI) in women with early cervical carcinoma is an independent prognostic factor. METHODS: The literature was reviewed using Medline and known literature to determine if LVSI is an independent risk factor as determined by multivariant analysis with survival being the end point in patients undergoing radical hysterectomy and pelvic lymphadenopathy. RESULTS: A total of 25 articles were identified that satisfied the evaluation criteria. Only three (12%) identified LVSI as an independent risk factor while 88% and 61% of those evaluated, noted lymph node metastasis and tumor size/depth of invasion to be significant risk factors for survival. CONCLUSIONS: Using LVSI as the sole determining factor for consideration of post radical hysterectomy radiotherapy appears questionable.
Authors: Beatrice Cormier; John P Diaz; Karin Shih; Rachael M Sampson; Yukio Sonoda; Kay J Park; Khaled Alektiar; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum Journal: Gynecol Oncol Date: 2011-05-13 Impact factor: 5.482
Authors: E R Nijhuis; H W Nijman; K A Oien; A Bell; K A ten Hoor; N Reesink-Peters; H M Boezen; H Hollema; A G J van der Zee Journal: J Clin Pathol Date: 2007-07 Impact factor: 3.411
Authors: Michael Frumovitz; Denis Querleu; Antonio Gil-Moreno; Philippe Morice; Anuja Jhingran; Mark F Munsell; Homer A Macapinlac; Eric Leblanc; Alejandra Martinez; Pedro T Ramirez Journal: J Minim Invasive Gynecol Date: 2013-07-31 Impact factor: 4.137
Authors: S Polterauer; C Grimm; G Hofstetter; N Concin; C Natter; A Sturdza; R Pötter; C Marth; A Reinthaller; G Heinze Journal: Br J Cancer Date: 2012-08-07 Impact factor: 7.640
Authors: Soo Young Jeong; Hyea Park; Myeong Seon Kim; Jun Hyeok Kang; E Sun Paik; Yoo-Young Lee; Tae Joong Kim; Jeong Won Lee; Byoung-Gie Kim; Duk Soo Bae; Chel Hun Choi Journal: Cancer Res Treat Date: 2019-10-29 Impact factor: 4.679